Development of a novel drug is a tedious process that requires immense investments of resources and time—on average, it takes from 8-10 years and capitalized …
Read More
Ginkgo Bioworks has introduced the Virtual Cell Pharmacology Initiative (VCPI) through its Ginkgo Datapoints division, creating what it describes as the first open-source pharmacological framework …
Read More
Antheia and TAPI have formed a strategic partnership to accelerate global commercialization of Antheia’s biosynthetic manufacturing platform for key starting materials (KSMs) and active pharmaceutical …
Read More
Aging research shifted from watching what happens to testing what can be changed. In the 1930s, lab studies in rats showed that eating fewer calories …
Read More
Terray Therapeutics introduced EMMI—Experimentation Meets Machine Learning—as an integrated platform that pairs ultra-dense microarray experimentation with a full AI stack used daily across its discovery …
Read More
According to our internal database, more than 500 life sciences companies in the categories "startups" and "scaleups" are actively using machine learning and deep learning-based …
Read More
